Literature DB >> 3472487

Naloxone in Gilles de la Tourette's syndrome.

N Gadoth, C R Gordon, J Streifler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3472487     DOI： 10.1002/ana.410210421

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  3 in total

1.  The treatment of Gilles de la Tourette syndrome by limbic leucotomy.

Authors:  M Robertson; M Doran; M Trimble; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.